METIS Biotechnologies Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

METIS Biotechnologies General Information

Description

Developer of rapid microbiological analytical solutions based in Panazol. France. The company develops, produces and markets rapid microbiological analytic solutions for the pharmaceutical, food and cosmetic industries using flow cytometry.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 10 avenue Pierre Cot
  • 87350 Panazol
  • France
Primary Industry
Biotechnology
Corporate Office
  • 10 avenue Pierre Cot
  • 87350 Panazol
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

METIS Biotechnologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore METIS Biotechnologies‘s full profile, request access.

Request a free trial

METIS Biotechnologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of rapid microbiological analytical solutions based in Panazol. France. The company develops, produces and mar
Biotechnology
Panazol, France
12 As of 2017

London, United Kingdom
 

Bengaluru, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

METIS Biotechnologies Competitors (4)

One of METIS Biotechnologies’s 4 competitors is GSK, a Corporation company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GSK Corporation London, United Kingdom
Biocon Formerly PE-Backed Bengaluru, India
Wockhardt Corporation Mumbai, India
Volastra Venture Capital-Backed New York, NY
To view METIS Biotechnologies’s complete competitors history, request access »

METIS Biotechnologies Patents

METIS Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2003283484-A1 Method for detecting and counting micro-organisms in a sample Active 01-Oct-2002
AU-2003283484-B2 Method for detecting and counting micro-organisms in a sample Inactive 01-Oct-2002
AU-2003283484-C1 Method for detecting and counting micro-organisms in a sample Inactive 01-Oct-2002
CA-2500464-A1 Method for detecting and counting micro-organisms in a sample Active 01-Oct-2002
CA-2500464-C Method for detecting and counting micro-organisms in a sample Inactive 01-Oct-2002 C12Q1/04
To view METIS Biotechnologies’s complete patent history, request access »

METIS Biotechnologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

METIS Biotechnologies FAQs

  • When was METIS Biotechnologies founded?

    METIS Biotechnologies was founded in 2000.

  • Where is METIS Biotechnologies headquartered?

    METIS Biotechnologies is headquartered in Panazol, France.

  • What is the size of METIS Biotechnologies?

    METIS Biotechnologies has 12 total employees.

  • What industry is METIS Biotechnologies in?

    METIS Biotechnologies’s primary industry is Biotechnology.

  • Is METIS Biotechnologies a private or public company?

    METIS Biotechnologies is a Private company.

  • What is METIS Biotechnologies’s current revenue?

    The current revenue for METIS Biotechnologies is .

  • Who are METIS Biotechnologies’s competitors?

    GSK, Biocon, Wockhardt, and Volastra are competitors of METIS Biotechnologies.

  • When was METIS Biotechnologies acquired?

    METIS Biotechnologies was acquired on 03-Jan-2017.

  • Who acquired METIS Biotechnologies?

    METIS Biotechnologies was acquired by Indicia Production.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process